ULTRAtab Laboratories recalls Back Relief II tablets due to CGMP deviations. Affected lots from Highland, NY. Consumers should contact for details.
CGMP Deviations
ULTRAtab Laboratories is recalling Back Relief II tablets (Acetaminophen 200 mg, Magnesium Salicylate 200 mg) because of manufacturing quality control issues. This recall affects specific lots produced in Highland, NY, and may pose risks related to product safety.
CGMP deviations refer to failures in manufacturing quality control processes. This could mean the tablets may not meet safety standards, potentially leading to health risks if used improperly.
People who purchased Back Relief II tablets from Highland, NY. Those with the specific NDC code 62959-740-00 or product codes M740LA are most at risk.
Check for the NDC code 62959-740-00 or product codes M740LA on the container. The affected lots are 19C022 and 19C023 from Highland, NY.
ULTRAtab Laboratories will provide details on how to handle the recalled product through their official channels.
Back Relief II (Acetaminophen 200 mg, Magnesium Salicylate 200 mg) Bulk Container from ULTRAtab Laboratories, Inc.
Bulk Lots: 19C022, 19C023
Look for NDC code 62959-740-00 or product codes M740LA on the container.
We’ve drafted a message you can send ULTRAtab to request your refund or repair — edit it as you like.
Subject: Recall D-0551-2022 — ULTRAtab ULTRAtab Hello, I own a ULTRAtab that is covered by recall D-0551-2022 from ULTRAtab. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.